Trial Profile
Safety and effectiveness of intravitreal bevacizumab and ranibizumab injections for treatment of retinal disease patients: an observational study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Aug 2018
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Ranibizumab
- Indications Diabetic macular oedema; Macular degeneration; Retinal disorders; Retinal vein occlusion
- Focus Adverse reactions
- 01 Aug 2018 Results published in the Clinical Drug Investigation.
- 16 Sep 2016 New trial record